Abbott Laboratories Earnings

Abbott Laboratories’s revenue jumped 7.16% since last year same period to $10974Mn in the Q4 2024. On a quarterly growth basis, Abbott Laboratories has generated 3.19% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit jumped 478.98% since last year same period to $9229Mn in the Q4 2024. On a quarterly growth basis, Abbott Laboratories has generated 460.69% jump in its net profits since last 3-months.

Abbott Laboratories’s net profit margin jumped 440.31% since last year same period to 84.1% in the Q4 2024. On a quarterly growth basis, Abbott Laboratories has generated 443.37% jump in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.07 - a -20.19% fall from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.07.

Abbott Laboratories’s earning per share (EPS) jumped 11.22% since last year same period to 1.09 in the Q1 2025. This indicates that the Abbott Laboratories has generated 11.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.59 dividend per share during the earnings announcement for Q1 2025.